Sanofi Drops Maze Licensing Deal After FTC Challenge | Goodw

The FTC announced yesterday that it would seek to block Sanofi’s proposed exclusive license agreement with Maze Therapeutics, having concluded that the transaction would “eliminate a...

Related Keywords

, Genyzme Corporation , M Maze Partnership , Maze Therapeutics , While Sanofi , Block Sanofi , Rare Disease Drug , Threatens Sanofi , Proposed License Agreement With Maze Therapeutics , Pharmaceutical Mergers , Merger Guidelines , Sherman Act , Sanofi Bets , Sanofi Deepens Pompe Disease Focus , Maze Partnership , Federal Trade Commission , Preliminary Injunction Pursuant , Federal Trade Commission Act , Maze Therapeutics Announces , Block Collaboration , License Agreement , Sanofi Regarding , Potential Oral Substrate Reduction Therapy , Pompe Disease , Pompe Drug ,